Detalhe da pesquisa
1.
Evolocumab in Pediatric Heterozygous Familial Hypercholesterolemia.
N Engl J Med
; 383(14): 1317-1327, 2020 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32865373
2.
Management of Hyperlipidemia in Very High and Extreme Risk Patients in Croatia: an observational study of treatment patterns and lipid control.
Acta Clin Croat
; 59(4): 641-649, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34285435
3.
Effects of Evolocumab on Vitamin E and Steroid Hormone Levels: Results From the 52-Week, Phase 3, Double-Blind, Randomized, Placebo-Controlled DESCARTES Study.
Circ Res
; 117(8): 731-41, 2015 Sep 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-26228031
4.
PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2): a randomised, double-blind, placebo-controlled trial.
Lancet
; 385(9965): 331-40, 2015 Jan 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-25282519
5.
Efficacy and Safety of the PCSK9 Inhibitor Evolocumab in Patients with Mixed Hyperlipidemia.
Cardiovasc Drugs Ther
; 30(3): 305-13, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-27240673
6.
Evolocumab use in clinical practice in Switzerland: final data of the observational HEYMANS cohort study.
Ther Adv Cardiovasc Dis
; 18: 17539447231213288, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38183273
7.
Evolocumab effectiveness in the real-world setting: Austrian data from the pan-European observational HEYMANS study.
Wien Klin Wochenschr
; 136(3-4): 77-86, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37525072
8.
Evolocumab-Based LDL-C Management in High and Very High Cardiovascular Risk Patients in German Clinical Practice: The HEYMANS Study.
Adv Ther
; 41(3): 1184-1200, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38286961
9.
Low-density lipoprotein cholesterol-lowering effects of AMG 145, a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 serine protease in patients with heterozygous familial hypercholesterolemia: the Reduction of LDL-C with PCSK9 Inhibition in Heterozygous Familial Hypercholesterolemia Disorder (RUTHERFORD) randomized trial.
Circulation
; 126(20): 2408-17, 2012 Nov 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-23129602
10.
Efficacy of cinacalcet with low-dose vitamin D in incident haemodialysis subjects with secondary hyperparathyroidism.
Nephrol Dial Transplant
; 28(5): 1241-54, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23328710
11.
Long-term persistence with evolocumab treatment and sustained reductions in LDL-cholesterol levels over 30 months: Final results from the European observational HEYMANS study.
Atherosclerosis
; 366: 14-21, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36696747
12.
Evolocumab is Initiated in Central and Eastern Europe at Much Higher LDL-C Levels Than Recommended in Guidelines: Results from the Observational HEYMANS Study.
J Cardiovasc Pharmacol Ther
; 28: 10742484231172847, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37218974
13.
Long-term treatment persistence and maintained reduction of LDL-cholesterol levels with evolocumab over 30 months: Results from the Spanish cohort of the European prospective HEYMANS study.
Clin Investig Arterioscler
; 35(6): 263-271, 2023.
Artigo
em Inglês, Espanhol
| MEDLINE | ID: mdl-37236829
14.
An observational cohort study of extended dosing (once every 2 weeks or once monthly) regimens with darbepoetin alfa in patients with chronic kidney disease not on dialysis: the EXTEND study.
Nephrol Dial Transplant
; 27(6): 2303-11, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-22140136
15.
Low-density lipoprotein cholesterol levels exceed the recommended European threshold for PCSK9i initiation: lessons from the HEYMANS study.
Eur Heart J Qual Care Clin Outcomes
; 8(4): 447-460, 2022 06 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35175350
16.
Cognitive function with evolocumab in pediatric heterozygous familial hypercholesterolemia.
J Clin Lipidol
; 16(5): 676-684, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36210291
17.
Erratum to: Efficacy and Safety of the PCSK9 Inhibitor Evolocumab in Patients with Mixed Hyperlipidemia.
Cardiovasc Drugs Ther
; 30(5): 537, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27497929
18.
Extended dosing of darbepoetin alfa in peritoneal dialysis patients.
BMC Nephrol
; 12: 13, 2011 Mar 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-21435267
19.
Clinical Management of High and Very High Risk Patients with Hyperlipidaemia in Central and Eastern Europe: An Observational Study.
Adv Ther
; 36(3): 608-620, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30758746
20.
Long-term safety, tolerability, and efficacy of evolocumab in patients with heterozygous familial hypercholesterolemia.
J Clin Lipidol
; 11(6): 1448-1457, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-29066265